28.07.2011 • News

DuPont's Q2 Sales up 17% per Share

DuPont reported that its second-quarter net income attributable to the company rose to $1.218  billion or $1.29 per share, from $1.159 billion or $1.26 per share in the same quarter last year. Second-quarter 2011 earnings were $1.37 per share, up 17% from $1.17 per share in the prior year, excluding significant items from both periods.

Analysts polled by Thomson Reuters expected the company to report earnings of $1.34 per share. Analysts' estimates typically exclude special items.
Net sales for the quarter rose to $10.26 billion from $8.62 billion in the prior year quarter. Six analysts had consensus revenue estimate of $9.86
billion for the quarter.

The company increased its full-year 2011 earnings outlook, excluding significant items, to a range of $3.90 to $4.05 per share.

The increase reflects strong second-quarter results, the expectation for continued global economic growth and about $0.05 per share full-year operating earnings from Danisco on an underlying basis. Prior guidance was a range of $3.65 to $3.85 per share, excluding the impact of Danisco. Analysts expect the company to report earnings of $3.87 per share for fiscal 2011.

The company's estimate for the impact of the Danisco acquisition on full-year reported earnings is now a reduction of $.18 to $.29 per share, versus the previous estimate of a $0.30 to $0.45 per share reduction.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read